| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2005 | Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis | Chen M.; Chen C.-P.; Shih J.-C.; Chou H.-C.; Yu C.-L.; Wang B.-T.; CHANG-YAO HSIEH | Fetal Diagnosis and Therapy | 32 | 28 | |
| 2005 | Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis | Chen M.; Chen C.-P.; Shih J.-C.; Chou H.-C.; CHIA-LI YU ; Wang B.-T.; Hsieh C.-Y. | Fetal Diagnosis and Therapy | 32 | 28 | |
| 2005 | Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis | Chen M.; Chen C.-P.; Shih J.-C.; HUNG-CHIEH CHOU ; Yu C.-L.; Wang B.-T.; Hsieh C.-Y. | Fetal Diagnosis and Therapy | 32 | 28 | |
| 2005 | Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis | Chen M.; Chen C.-P.; JIN-CHUNG SHIH ; Chou H.-C.; Yu C.-L.; Wang B.-T.; Hsieh C.-Y. | Fetal Diagnosis and Therapy | | 28 | |
| 2011 | Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: Report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010 | Wang H.; Chen M.; Xu Y.; Sun H.; Yang Q.; Hu Y.; Cao B.; Chu Y.; Liu Y.; Zhang R.; Yu Y.; Sun Z.; Zhuo C.; Ni Y.; Hu B.; Tan T.Y.; PO-REN HSUEH; Wang J.-H.; Ko W.-C.; Chen Y.-H.; Wahjono H. | International Journal of Antimicrobial Agents | 38 | 35 | |
| 2011 | Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: Report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010 | Wang H.; Chen M.; Xu Y.; Sun H.; Yang Q.; Hu Y.; Cao B.; Chu Y.; Liu Y.; Zhang R.; Yu Y.; Sun Z.; Zhuo C.; Ni Y.; Hu B.; Tan T.Y.; PO-REN HSUEH ; Wang J.-H.; Ko W.-C.; Chen Y.-H.; Wahjono H. | International Journal of Antimicrobial Agents | 38 | 35 | |
| 2020 | Application of deep learning image assessment software VeriSee? for diabetic retinopathy screening | Hsieh Y.-T.; LEE-MING CHUANG ; Jiang Y.-D.; Chang T.-J.; Yang C.-M.; Yang C.-H.; Chan L.-W.; Kao T.-Y.; Chen T.-C.; Lin H.-C.; Tsai C.-H.; Chen M. | Journal of the Formosan Medical Association | 0 | 9 | |
| 2020 | Application of deep learning image assessment software VeriSee? for diabetic retinopathy screening | Hsieh Y.-T.; Chuang L.-M.; YI-DER JIANG; Chang T.-J.; Yang C.-M.; Yang C.-H.; Chan L.-W.; Kao T.-Y.; Chen T.-C.; Lin H.-C.; Tsai C.-H.; Chen M. | Journal of the Formosan Medical Association | 0 | 9 | |
| 2020 | Application of deep learning image assessment software VeriSee? for diabetic retinopathy screening | Hsieh Y.-T.; Chuang L.-M.; Jiang Y.-D.; TIEN-JYUN CHANG ; Yang C.-M.; Yang C.-H.; Chan L.-W.; Kao T.-Y.; Chen T.-C.; Lin H.-C.; Tsai C.-H.; Chen M. | Journal of the Formosan Medical Association | 0 | 9 | |
| 2020 | Application of deep learning image assessment software VeriSee? for diabetic retinopathy screening | Hsieh Y.-T.; Chuang L.-M.; YI-DER JIANG; Chang T.-J.; Yang C.-M.; Yang C.-H.; Chan L.-W.; Kao T.-Y.; Chen T.-C.; Lin H.-C.; Tsai C.-H.; Chen M. | Journal of the Formosan Medical Association | 0 | 9 | |
| 2021 | Application of deep learning image assessment software VeriSee? for diabetic retinopathy screening | Hsieh Y.-T.; Chuang L.-M.; YI-DER JIANG ; Chang T.-J.; Yang C.-M.; Yang C.-H.; Chan L.-W.; Kao T.-Y.; Chen T.-C.; Lin H.-C.; Tsai C.-H.; Chen M. | Journal of the Formosan Medical Association | 0 | 9 | |
| 2021 | Application of deep learning image assessment software VeriSee? for diabetic retinopathy screening | Hsieh Y.-T.; Chuang L.-M.; Jiang Y.-D.; Chang T.-J.; Yang C.-M.; Yang C.-H.; Chan L.-W.; Kao T.-Y.; TA-CHING CHEN ; Lin H.-C.; Tsai C.-H.; Chen M. | Journal of the Formosan Medical Association | | 9 | |
| 2018 | Application of molecular cytogenetic techniques to characterize the aberrant Y chromosome arising de novo in a male fetus with mosaic 45,X and solve the discrepancy between karyotyping, chromosome microarray, and multiplex ligation dependent probe amplification | SHIN-YU LIN ; Lee C.-N; Peng A.-Y; Yuan T.-J; Lee D.-J; Lin W.-H; Ma G.-C; Chen M. | Application of molecular cytogenetic techniques to characterize the aberrant Y chromosome arising de novo in a male fetus with mosaic 45,X and solve the discrepancy between karyotyping, chromosome microarray, and multiplex ligation dependent probe amplification | 3 | 4 | |
| 2018 | Application of molecular cytogenetic techniques to characterize the aberrant Y chromosome arising de novo in a male fetus with mosaic 45,X and solve the discrepancy between karyotyping, chromosome microarray, and multiplex ligation dependent probe amplification | Lin S.-Y.; CHIEN-NAN LEE ; Peng A.-Y.; Yuan T.-J.; Lee D.-J.; Lin W.-H.; Ma G.-C.; Chen M. | Journal of the Formosan Medical Association | | 4 | |
| 2018 | Asian organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Intestinal Research | | 17 | |
| 2018 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Intestinal Research | | 9 | |
| 2018 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Journal of Gastroenterology and Hepatology (Australia) | | 14 | |
| 2021 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia | Ran Z.; Wu K.; Matsuoka K.; Jeen Y.T.; SHU-CHEN WEI ; Ahuja V.; Chen M.; Hu P.-J.; Andoh A.; Kim H.J.; Yang S.-K.; Watanabe M.; Ng S.C.; Hibi T.; Hilmi I.N.; Suzuki Y.; Han D.S.; Leung W.K.; Sollano J.; Ooi C.J.; Qian J. | Journal of Gastroenterology and Hepatology (Australia) | | 6 | |
| 2018 | Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment | Park D.I.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Journal of Gastroenterology and Hepatology (Australia) | | 8 | |
| 2013 | Band gap engineering of chemical vapor deposited graphene by in situ BN doping | Chang C.-K.; Kataria S.; Kuo C.-C.; Ganguly A.; Wang B.-Y.; Hwang J.-Y.; Huang K.-J.; Yang W.-H.; Wang S.-B.; Chuang C.-H.; Chen M.; Huang C.-I.; Pong W.-F.; Song K.-J.; Chang S.-J.; Guo J.-H.; Tai Y.; Tsujimoto M.; Isoda S.; Chen C.-W.; Chen L.-C.; Chen K.-H.; CHUN-WEI CHEN | ACS Nano | 182 | 221 | |
